Tetrahydropyridopyrimidines as covalent inhibitors of kras-g12c Deposition Author(s): Vigers, G.P.
Date: 2018-11-13 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Homo Sapiens Sequences Data: 6N2J_A
Tetrahydropyridopyrimidines as covalent inhibitors of kras-g12c Deposition Author(s): Vigers, G.P.
Date: 2018-11-13 Method: X-RAY DIFFRACTION Resolution: 1.72 Å Organism(s): Homo Sapiens Sequences Data: 6N2K_A
Phosphorylated erk2 with amp-pnp Deposition Author(s): Smith, D. , Vigers, G.P.
Date: 2019-04-25 Method: X-RAY DIFFRACTION Resolution: 2.9 Å Organism(s): Homo Sapiens Sequences Data: 6OPG_A
Phosphorylated erk2 with gdc-0994 Deposition Author(s): Smith, D. , Vigers, G.P.
Date: 2019-04-25 Method: X-RAY DIFFRACTION Resolution: 2.4 Å Organism(s): Homo Sapiens Sequences Data: 6OPH_A
Phosphorylated erk2 with sch-cpd336 Deposition Author(s): Smith, D. , Vigers, G.P.
Date: 2019-04-25 Method: X-RAY DIFFRACTION Resolution: 3 Å Organism(s): Homo Sapiens Sequences Data: 6OPI_A
Phosphorylated erk2 with vertex-11e Deposition Author(s): Rudolph, J. , Vigers, G.P.
Date: 2019-04-25 Method: X-RAY DIFFRACTION Resolution: 2.54 Å Organism(s): Rattus Norvegicus Sequences Data: 6OPK_A
Identification of the clinical development candidate mrtx849, a covalent krasg12c inhibitor for the treatment of cancer Deposition Author(s): Smith, D.J. , Vigers, G.P.
Date: 2019-10-28 Method: X-RAY DIFFRACTION Resolution: 2.27 Å Organism(s): Homo Sapiens Sequences Data: 6USX_A , 6USX_B
Identification of the clinical development candidate mrtx849, a covalent krasg12c inhibitor for the treatment of cancer Deposition Author(s): Smith, D.J. , Vigers, G.P.
Date: 2019-10-28 Method: X-RAY DIFFRACTION Resolution: 2.03 Å Organism(s): Homo Sapiens Sequences Data: 6USZ_A
Identification of the clinical development candidate mrtx849, a covalent krasg12c inhibitor for the treatment of cancer Deposition Author(s): Smith, D.J. , Vigers, G.P.
Date: 2019-10-29 Method: X-RAY DIFFRACTION Resolution: 1.94 Å Organism(s): Homo Sapiens Sequences Data: 6UT0_A , 6UT0_B , 6UT0_C , 6UT0_D
Co-crystal structure of phosphorylated erk2 in complex with erk1/2 inhibitor #16 Deposition Author(s): Anderson, J.W. , Vigers, G.P.
Date: 2023-09-18 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Homo Sapiens Sequences Data: 8U8J_A